Mirae Asset Global Investments’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,359
| Closed | -$2.79M | – | 2647 |
|
|
2022
Q3 | $2.79M | Sell |
11,359
-524
| -4% | -$129K | 0.01% | 1010 |
|
|
2022
Q2 | $2.94M | Buy |
+11,883
| New | +$2.94M | 0.01% | 1010 |
|
|
2021
Q4 | – | Sell |
-7,062
| Closed | -$2.3M | – | 1801 |
|
|
2021
Q3 | $2.3M | Buy |
7,062
+1,152
| +19% | +$375K | 0.01% | 1079 |
|
|
2021
Q2 | $1.84M | Buy |
5,910
+627
| +12% | +$196K | 0.01% | 1088 |
|
|
2021
Q1 | $1.68M | Buy |
5,283
+566
| +12% | +$180K | 0.01% | 992 |
|
|
2020
Q4 | $1.53M | Buy |
4,717
+934
| +25% | +$303K | 0.01% | 1015 |
|
|
2020
Q3 | $1.05M | Buy |
3,783
+836
| +28% | +$232K | 0.01% | 952 |
|
|
2020
Q2 | $712K | Buy |
2,947
+229
| +8% | +$55.3K | ﹤0.01% | 1017 |
|
|
2020
Q1 | $394K | Sell |
2,718
-10,659
| -80% | -$1.55M | ﹤0.01% | 1100 |
|
|
2019
Q4 | $2.28M | Buy |
13,377
+4,854
| +57% | +$828K | 0.01% | 718 |
|
|
2019
Q3 | $1.52M | Buy |
8,523
+2,408
| +39% | +$428K | 0.01% | 784 |
|
|
2019
Q2 | $1.59M | Buy |
6,115
+1,169
| +24% | +$305K | 0.01% | 778 |
|
|
2019
Q1 | $1.41M | Buy |
4,946
+277
| +6% | +$79.1K | 0.01% | 728 |
|
|
2018
Q4 | $1.52M | Sell |
4,669
-95
| -2% | -$30.9K | 0.01% | 669 |
|
|
2018
Q3 | $2.14M | Sell |
4,764
-1,197
| -20% | -$538K | 0.02% | 640 |
|
|
2018
Q2 | $2.44M | Sell |
5,961
-765
| -11% | -$313K | 0.03% | 323 |
|
|
2018
Q1 | $1.96M | Sell |
6,726
-3,724
| -36% | -$1.08M | 0.03% | 378 |
|
|
2017
Q4 | $1.96M | Buy |
+10,450
| New | +$1.96M | 0.03% | 353 |
|